Menotropin Injection 225 Iu/ 0.75 Ml

Product Name: Menotropin Injection ( Highly Purified)

Brand Name: Eugon XP PFS 225 IU

Strength: 225 IU/ 0.75 ML

Packing: Single PFS Per Box 

Pharmaceutical Composition: Menotropin, a combination of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) extracted from the urine of postmenopausal women.

Formulation: Available as a lyophilized powder for reconstitution into an injectable solution.

Mechanism of Action:

FSH: Stimulates the growth and development of ovarian follicles in females.

LH: Triggers ovulation and promotes the production of progesterone in females.

Assisted Reproductive Technologies (ART): Used for controlled ovarian stimulation in women undergoing in vitro fertilization (IVF) or other fertility treatments.

Ovulation Induction: Employed to stimulate ovulation in women with anovulatory infertility, such as those with polycystic ovary syndrome (PCOS) or hypothalamic amenorrhea.

Administration: Subcutaneous or Intramuscular: Administered once daily, typically starting on day 2-4 of the menstrual cycle, with dosage individualized based on patient response and treatment protocol.

Precautions:Ovarian Hyperstimulation Syndrome (OHSS): Risk of developing OHSS, characterized by ovarian enlargement and fluid retention; close monitoring and cycle cancellation may be necessary to mitigate risk.

Multiple Pregnancy: Increased risk of multiple gestation (e.g., twins, triplets); careful monitoring and patient counseling essential to minimize risk and optimize outcomes.

Monitoring: Regular monitoring of ovarian response through ultrasound examinations and serum hormone assays to assess follicular growth and adjust treatment protocols as needed.

Storage: Should be stored in accordance with pharmaceutical guidelines, typically at controlled room temperature, protected from light

Adverse Effects: Common adverse effects may include injection site reactions, abdominal discomfort, breast tenderness, or mood swings.

Menotropin For Injection plays a crucial role in fertility treatments by stimulating follicular growth and ovulation in women undergoing ART or ovulation induction therapy, offering a potent tool for optimizing reproductive outcomes when administered subcutaneously or intramuscularly with careful monitoring and consideration of potential adverse effects.